Diagnosing Ring-Enhancing Lesions in the Brain of a Patient With AIDS
Without Brain Biopsy: A Case of Central Nervous System Histoplasmoma.
Beekman R, Hu JM, Aronin SI, Malinis MF.
et al
Neurohospitalist. 2018
Apr;8(2):86-91.
Abstract
Verbal episodic memory profiles in
HIV-Associated Neurocognitive Disorders (HAND): A comparison with
Huntington's disease and mesial temporal lobe epilepsy.
Doyle KL, Woods SP, McDonald CR,
et al
Appl Neuropsychol Adult.
2017 Aug 29:
Abstract
HIV-associated opportunistic CNS infections: pathophysiology,
diagnosis and treatment.
Bowen LN, Smith B, Reich D,
et al
Nat Rev Neurol.
2016 Oct 27;12(11):662-674.
Abstract
CNS Impact of Perinatal HIV Infection and Early Treatment:
the Need for Behavioral Rehabilitative Interventions Along with Medical
Treatment and Care.
Boivin MJ, Ruiseñor-Escudero H,
Familiar-Lopez I.
Curr HIV/AIDS Rep. 2016 Oct 25.
Review
Abstract
Solving the Blood-Brain Barrier Challenge for the Effective
Treatment of HIV Replication in the Central Nervous System.
Bertrand L, Nair M, Toborek M.
Curr Pharm Des.
2016 Jul 26.
Abstract
Is there a role for maraviroc to treat HIV-associated central nervous system
white matter disease?
Ball C, Sudhanva M, Jarosz J, et
al
AIDS. 2016
Jan;30(2):334-6
Abstract
Neuropsychological Impairment in Acute HIV and the Effect of
Immediate Antiretroviral Therapy.
Kore I, Ananworanich J, Valcour V, Fletcher . et al
J Acquir Immune Defic Syndr. 2015
Dec 1;70(4):393-9.
Abstract
Neurocognitive decline in HIV patients is associated with ongoing T-cell
activation in the cerebrospinal fluid.
Grauer OM, Reichelt D, Grüneberg U, et al
Ann Clin Transl Neurol. 2015 Sep;2(9):906-19.
Abstract
FULL-TEXT ARTICLE
Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central
Nervous System Early in the Course of Infection.
Sturdevant CB, Joseph SB, Schnell G, et al
PLoS Pathog.
2015 Mar 26;11(3):e1004720.
Paper
Multiple sclerosis and HIV-1 infection: case report of a HIV
controller.
Chin JH.
J Neurovirol. 2015 Mar 24.
Abstract
An Update of the Review of Neuropsychological Consequences of
HIV and Substance Abuse: A Literature Review and Implications for Treatment
and Future Research.
Norman LR, Basso M.
Curr Drug Abuse Rev. 2015 Mar 9
Abstract
Combination of Methamphetamine and HIV-1 gp120 causes distinct long-term
alterations of behavior, gene expression, and injury
in the central nervous system.
Hoefer MM, Sanchez AB, Maung R, et al
Exp Neurol. 2014 Sep 19.
Abstract
Is the central nervous system a reservoir of HIV-1?
Gray LR, Roche M, Flynn JK, et al
Curr Opin HIV AIDS.
2014 Sep 6
Abstract
B-68Relationship between Central Nervous System
Penetrative-Effectiveness (CPE) Index of
HIV-Medication and Figural Fluency Performance is Mediated by Average
Cluster Size.
Dasher N, Williams C, DeCou C, et al
Arch Clin Neuropsychol.
2014
Sep;29(6):562.
Abstract
B-51Cognitive, Psychiatric, and Personality Factors Associated with Risk
Behavior in HIV+ Men and Women.
Arentoft A, Van Dyk K, Thames A, et al
Arch Clin Neuropsychol. 2014
Sep;29(6):556.
Abstract
B-66Is There a Cognitive Contribution to Proactive Coping Behaviors between
Adults with and without HIV?
Vance D, Humphrey S.
Arch Clin Neuropsychol.
2014 Sep;29(6):561
Abstract
B-54Changes in Neurocognitive Intra-Individual Variability Signal Declines
in Medication Adherence in HIV/AIDS.
Thaler N, Sayegh P, Arentoft A, et al
Arch Clin Neuropsychol.
2014 Sep;29(6):557.
Abstract
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive
Disorders.
Purohit V, Rapaka RS, Rutter J.
J Neuroimmune Pharmacol. 2014 Jul 12.
Abstract
Update on HIV Dementia and HIV-Associated
Neurocognitive Disorders.
Brew BJ, Chan P.
Curr
Neurol Neurosci Rep. 2014
Aug;14(8):468.
Abstract
Chronic Central Nervous System Expression of HIV-1 Tat Leads to Accelerated
Rarefaction of Neocortical Capillaries and Loss of Red Blood Cell Velocity
Heterogeneity.
Silva JN, Polesskaya O, Wei HS,et
al
Microcirculation. 2014 May
11.
Abstract
Can high central nervous system penetrating antiretroviral regimens protect
against the onset of HIV-associated neurocognitive disorders?
Vassallo M, Durant J, Biscay V, et al
AIDS. 2014 Feb 20;28(4):493-501
Abstract
Antiretroviral drugs induce oxidative stress and neuronal damage
in the central nervous system.
Akay C, Cooper M, Odeleye A, et al
J Neurovirol. 2014 Jan 14..
Abstract
Randomized Trial of CNS-Targeted Antiretrovirals for HIV-Associated
Neurocognitive Disorder.
Ellis RJ, Letendre S, Vaida F, et al
Clin Infect Dis. 2013
Dec 18.
Abstract
HIV-1 and Alcohol: Interactions in the Central Nervous System.
Silverstein PS, Kumar A.
Alcohol Clin Exp Res. 2013 Oct 17.
Abstract
Rivastigmine for HIV-associated neurocognitive disorders: A randomized
crossover pilot study.
Simioni S, Cavassini M, Annoni JM, et al
Neurology. 2013 Jan 23
Abstract |
Nervous
System Main Page
Documents identified with this icon are in Portable
Document Format (PDF) and require the
